Philippe Lettéron

6.2k total citations
71 papers, 5.0k citations indexed

About

Philippe Lettéron is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Philippe Lettéron has authored 71 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 24 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Philippe Lettéron's work include Pharmacogenetics and Drug Metabolism (19 papers), Drug-Induced Hepatotoxicity and Protection (17 papers) and Metabolism and Genetic Disorders (12 papers). Philippe Lettéron is often cited by papers focused on Pharmacogenetics and Drug Metabolism (19 papers), Drug-Induced Hepatotoxicity and Protection (17 papers) and Metabolism and Genetic Disorders (12 papers). Philippe Lettéron collaborates with scholars based in France, United States and Austria. Philippe Lettéron's co-authors include Dominique Pessayre, Bernard Fromenty, Alain Berson, Claude Degott, Abdellah Mansouri, Gérard Feldmann, Dominique Larrey, Richard Moreau, Gilles Labbe and Marie‐Anne Robin and has published in prestigious journals such as Nature Communications, Blood and Gastroenterology.

In The Last Decade

Philippe Lettéron

71 papers receiving 4.8k citations

Peers

Countries citing papers authored by Philippe Lettéron

Since Specialization

Citations

This map shows the geographic impact of Philippe Lettéron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lettéron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lettéron more than expected).

Fields of papers citing papers by Philippe Lettéron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lettéron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lettéron. The network helps show where Philippe Lettéron may publish in the future.

Co-authorship network of co-authors of Philippe Lettéron

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Lettéron. A scholar is included among the top collaborators of Philippe Lettéron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Lettéron. Philippe Lettéron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Success of Escherichia coli O25b:H4 Sequence Type 131 Clade C Associated with a Decrease in Virulence 2020 ·Infection and Immunity ·(unknown), Alexandra Baron, François Blanquart, Sara Dion, Cassandra Pouget, Philippe Lettéron, Saskia-Camille Flament-Simon, Olivier Clermont, Érick Denamur, Marie-Hélène Nicolas-Chanoine	16
2	Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver 2018 ·Nature Communications ·Pushpa Hegde, Emmanuel Weiss, Valérie Paradis, JingHong Wan, Morgane Mabire, Sukriti Sukriti, Pierre‐Emmanuel Rautou, Miguel Albuquerque, (unknown), (unknown), Gladys Ferrere, Hélène Gilgenkrantz, Badr Kiaf, Amine Toubal, Lucie Beaudoin, Philippe Lettéron, Richard Moreau, Agnès Lehuen, Sophie Lotersztajn	170
3	NOX1-derived ROS drive the expression of Lipocalin-2 in colonic epithelial cells in inflammatory conditions 2018 ·Mucosal Immunology ·(unknown), (unknown), Dan Liu, (unknown), Viviana Marzaioli, (unknown), (unknown), Coralie Pintard, Philippe Lettéron, Margarita Hurtado-Nédelec, Jamel El‐Benna, Jean‐Claude Marie, Aurélie Sannier, Anne-Laure Pelletier, Pham My‐Chan Dang	54
4	Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver 2018 ·Gut ·Aı̈da Habib, (unknown), JingHong Wan, Pushpa Hegde, Morgane Mabire, (unknown), Lara Ribeiro‐Parenti, Maude Le Gall, Philippe Lettéron, Nathalie Pilard, Abdellah Mansouri, Arthur Brouillet, Matteo Tardelli, Emmanuel Weiss, Pauline Le Faouder, Hervé Guillou, Benjamin F. Cravatt, Richard Moreau, Michael Trauner, Sophie Lotersztajn	65
5	Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model 2016 ·Haematologica ·Sarah Millot, Constance Delaby, Boualem Moulouel, Thibaud Lefèbvre, Nathalie Pilard, Nicolas Ducrot, Cécile Ged, Philippe Lettéron, Lucia De Franceschi, (unknown), Carole Beaumont, Laurent Gouya, Hubert de Verneuil, Saı̈d Lyoumi, Hervé Puy, Zoubida Karim	14
6	Hepatic Proliferation and Angiogenesis Markers Are Increased after Portal Deprivation in Rats: A Study of Molecular, Histological and Radiological Changes 2015 ·PLoS ONE ·Florent Guérin, Mathilde Wagner, (unknown), Magaly Zappa, Magali Fasseu, Valérie Paradis, Valérie Vilgrain, Bernard E. Van Beers, Josette Legagneux, Richard Moreau, Philippe Lettéron	7
7	Central role of mitochondria in drug-induced liver injury 2011 ·Drug Metabolism Reviews ·Dominique Pessayre, Bernard Fromenty, Alain Berson, Marie‐Anne Robin, Philippe Lettéron, Richard Moreau, Abdellah Mansouri	201
8	Chronic Ethanol Consumption Lessens the Gain of Body Weight, Liver Triglycerides, and Diabetes in Obese ob/ob Mice 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Bernard Fromenty, Nathalie Vadrot, Julie Massart, Bruno Turlin, Nadège Barri‐Ova, Philippe Lettéron, Alain Fautrel, Marie‐Anne Robin	41
9	Positive Regulatory Control Loop between Gut Leptin and Intestinal GLUT2/GLUT5 Transporters Links to Hepatic Metabolic Functions in Rodents 2009 ·PLoS ONE ·Yassine Sakar, Corinne Nazaret, Philippe Lettéron, (unknown), (unknown), Benoı̂t Viollet, Robert Ducroc, André Bado	56
10	Punicic Acid a Conjugated Linolenic Acid Inhibits TNFα-Induced Neutrophil Hyperactivation and Protects from Experimental Colon Inflammation in Rats 2009 ·PLoS ONE ·Tarek Boussetta, Houssam Raad, Philippe Lettéron, Marie‐Anne Gougerot‐Pocidalo, Jean‐Claude Marie, Fathi Driss, Jamel El‐Benna	106
11	Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia 2008 ·Critical Care Medicine ·Sigismond Lasocki, Sarah Millot, Valérie Andrieu‐Ponel, Philippe Lettéron, Nathalie Pilard, Françoise Muzeau, Olivier Thibaudeau, Philippe Montravers, Carole Beaumont	66
12	Alcohol increases tumor necrosis factor α and decreases nuclear factor‐κb to activate hepatic apoptosis in genetically obese mice† 2005 ·Hepatology ·Marie‐Anne Robin, Christine Demeilliers, Angéla Sutton, Valérie Paradis, (unknown), Sylvie Dubois, Odile Poirel, Philippe Lettéron, Dominique Pessayre, Bernard Fromenty	66
13	Prolonged, But Not Acute, Glutathione Depletion Promotes Fas–Mediated Mitochondrial Permeability Transition and Apoptosis in Mice 2001 ·Hepatology ·D. Haouzi, (unknown), Marina Tinel, Nathalie Vadrot, (unknown), Philippe Lettéron, Alain Moreau, Gérard Feldmann, Daniel Fau, Dominique Pessayre	57
14	Effect of Stavudine on Mitochondrial Genome and Fatty Acid Oxidation in Lean and Obese Mice 2001 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), (unknown), (unknown), Philippe Lettéron, (unknown), Gilles Peytavin, Claude Degott, Dominique Pessayre, Bernard Fromenty	44
15	Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes 2000 ·Hepatology ·D. Haouzi, (unknown), Alain Moreau, Claude Moulis, Gérard Feldmann, Marie‐Anne Robin, Philippe Lettéron, Daniel Fau, Dominique Pessayre	84
16	Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice 1990 ·Biochemical Pharmacology ·Philippe Lettéron, Gilles Labbe, Claude Degott, Alain Berson, Bernard Fromenty, Marcel Delaforge, Dominique Larrey, Dominique Pessayre	217
17	Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450 1990 ·Biochemical Pharmacology ·Dominique Larrey, Marina Tinel, Philippe Lettéron, Patrick Maurel, Jacqueline Loeper, Jacques Belghiti, Dominique Pessayre	20
18	Metabolic activation of the antidepressant tianeptine 1989 ·Biochemical Pharmacology ·Philippe Lettéron, Véronique Descatoire, Marina Tinel, Patrick Maurel, Gilles Labbe, Jacqueline Loeper, Dominique Larrey, E Fréneaux, Dominique Pessayre	14
19	Metabolic activation of the antidepressant tianeptine 1989 ·Biochemical Pharmacology ·Philippe Lettéron, Gilles Labbe, Véronique Descatoire, Claude Degott, Jacqueline Loeper, Marina Tinel, Dominique Larrey, Dominique Pessayre	8
20	Inhibitory effects of nilutamide, a new androgen receptor antagonist, on mouse and human liver cytochrome P-450 1989 ·Biochemical Pharmacology ·G Babany, Marina Tinel, Philippe Lettéron, E Fréneaux, Alain Berson, Dominique Larrey, Dominique Pessayre	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact